{"id":4408,"date":"2025-12-31T13:58:57","date_gmt":"2025-12-31T13:58:57","guid":{"rendered":"https:\/\/www.lifeviz.com\/publication\/tratamiento-de-lesiones-cutaneas-desfigurantes-en-neurofibromatosis-tipo-1-con-everolimus-un-ensayo-de-fase-ii-abierto-de-un-solo-brazo-drugs-in-rd-2018\/"},"modified":"2025-12-31T13:58:57","modified_gmt":"2025-12-31T13:58:57","slug":"tratamiento-de-lesiones-cutaneas-desfigurantes-en-neurofibromatosis-tipo-1-con-everolimus-un-ensayo-de-fase-ii-abierto-de-un-solo-brazo-drugs-in-rd-2018","status":"publish","type":"publication","link":"https:\/\/www.lifeviz.com\/es\/publication\/tratamiento-de-lesiones-cutaneas-desfigurantes-en-neurofibromatosis-tipo-1-con-everolimus-un-ensayo-de-fase-ii-abierto-de-un-solo-brazo-drugs-in-rd-2018\/","title":{"rendered":"Tratamiento de lesiones cut\u00e1neas desfigurantes en neurofibromatosis tipo 1 con everolimus: un ensayo de fase II, abierto, de un solo brazo – Drugs in R&D (2018)"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","categoriepublication":[],"class_list":["post-4408","publication","type-publication","status-publish","hentry"],"acf":{"type":"","mise_en_avant":false,"lien":"https:\/\/link.springer.com\/article\/10.1007\/s40268-018-0248-6"},"_links":{"self":[{"href":"https:\/\/www.lifeviz.com\/es\/wp-json\/wp\/v2\/publication\/4408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifeviz.com\/es\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.lifeviz.com\/es\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.lifeviz.com\/es\/wp-json\/wp\/v2\/media?parent=4408"}],"wp:term":[{"taxonomy":"categoriepublication","embeddable":true,"href":"https:\/\/www.lifeviz.com\/es\/wp-json\/wp\/v2\/categoriepublication?post=4408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}